Provided by Tiger Fintech (Singapore) Pte. Ltd.

Park Hotels & Resorts Inc.

11.20
-0.1400-1.23%
Post-market: 11.14-0.0599-0.53%19:31 EDT
Volume:2.92M
Turnover:32.66M
Market Cap:2.24B
PE:18.38
High:11.30
Open:11.28
Low:11.07
Close:11.34
Loading ...

Q4 2024 Park Hotels & Resorts Inc Earnings Call

Thomson Reuters StreetEvents
·
21 Feb

Park Hotels & Resorts Inc (PK) Q4 2024 Earnings Call Highlights: Strategic Divestments and ...

GuruFocus.com
·
21 Feb

Aptose Announces Positive Clinical Safety Review Committee (CSRC) Approval to Dose Escalate in Phase 1/2 Tuscany Trial of Frontline Triple Drug Therapy with Tuspetinib Amid Complete Responses and Favorable Safety in First Cohort

GlobeNewswire
·
20 Feb

Truist Financial Sticks to Its Buy Rating for Park Hotels & Resorts (PK)

TIPRANKS
·
20 Feb

Agios to Present at the TD Cowen 45th Annual Healthcare Conference on March 3, 2025

GlobeNewswire
·
20 Feb

Compared to Estimates, Park Hotels & Resorts (PK) Q4 Earnings: A Look at Key Metrics

Zacks
·
20 Feb

Park Hotels & Resorts (PK) Q4 FFO Miss Estimates

Zacks
·
20 Feb

Park Hotels & Resorts Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
20 Feb

Park Hotels & Resorts Q4 Adjusted FFO, Revenue Decline

MT Newswires Live
·
20 Feb

Park Hotels & Resorts: Q4 Earnings Snapshot

Associated Press Finance
·
20 Feb

Park Hotels & Resorts Inc: Outlook FY25 Adjusted Ffo per Share $1.90-$2.20

THOMSON REUTERS
·
20 Feb

Park Hotels & Resorts Q4 2024 AFFO $0.39, Sales $625.000M Beat $606.595M Estimate

Benzinga
·
20 Feb

BRIEF-Park Hotels & Resorts Q4 EPS USD 0.32 Vs. IBES Estimate USD 0.06

Reuters
·
20 Feb

Park Hotels & Resorts Q4 Adjusted Revpar USD 179.02

THOMSON REUTERS
·
20 Feb

Park Hotels & Resorts Q4 Hotel Adj. Ebitda Margin 24.6%

THOMSON REUTERS
·
20 Feb

Park Hotels & Resorts Inc. Reports Fourth Quarter and Full-Year 2024 Results and Announces Transformative Renovation at the Royal Palm South Beach Miami

Business Wire
·
20 Feb

BioMarin Reports Fourth Quarter and Full Year 2024 Results; Sets Full Year 2025 Guidance

PR Newswire
·
20 Feb

JPO Grants Acurx Pharmaceuticals Patent in Japan for DNA Polymerase IIIC Inhibitors

PR Newswire
·
19 Feb

Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 2Q 2025

Newsfile
·
19 Feb

IIPR's Q4 Earnings Coming Up: Key Factors to Impact the Stock

Zacks
·
18 Feb